Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications

Ramelteon is a tricyclic synthetic analog of melatonin that acts specifically on MT(1) and MT(2) melatonin receptors. Ramelteon is the first melatonin receptor agonist approved by the Food and Drug Administration (FDA) for the treatment of insomnia characterized by sleep onset difficulties. Ramelteo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandi-Perumal, Seithikurippu R., Spence, D. Warren, Verster, Joris C., Srinivasan, Venkatramanujam, Brown, Gregory M., Cardinali, Daniel P., Hardeland, Rüdiger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663615/
https://www.ncbi.nlm.nih.gov/pubmed/23861638
http://dx.doi.org/10.4137/JCNSD.S1611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663615/
https://www.ncbi.nlm.nih.gov/pubmed/23861638
http://dx.doi.org/10.4137/JCNSD.S1611

Ejemplares similares